82 related articles for article (PubMed ID: 20718658)
1. Changes in composition of IgM polymers in patients suffering from recurrent urinary bacterial infections after bacterial immunization treatment.
Petrušić V; Stojanović M; Zivković I; Inić-Kanada A; Dimitrijević L
Immunol Invest; 2010; 39(8):781-95. PubMed ID: 20718658
[TBL] [Abstract][Full Text] [Related]
2. Changes in pools of autoantibodies and anti-bacterial antibodies in patients suffering from recurrent infections of the urinary tract and undergoing bacterial immunization treatment.
Stojanović M; Inić-Kanada A; Popović Z; Zivković I; Dimitrijević L
Immunol Lett; 2004 Jun; 94(1-2):123-33. PubMed ID: 15234544
[TBL] [Abstract][Full Text] [Related]
3. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
[TBL] [Abstract][Full Text] [Related]
4. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.
Uehling DT; Hopkins WJ; Beierle LM; Kryger JV; Heisey DM
J Infect Dis; 2001 Mar; 183 Suppl 1():S81-3. PubMed ID: 11171022
[No Abstract] [Full Text] [Related]
5. [Vaccinations in recurrent urinary tract infections--an observation study relating to health economy].
Lenk VS; Dorsch B
Aktuelle Urol; 2009 Nov; 40(6):360-5. PubMed ID: 19899016
[TBL] [Abstract][Full Text] [Related]
6. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
[TBL] [Abstract][Full Text] [Related]
7. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
Hidalgo H; Moore C; Leiva LE; Sorensen RU
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ
Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006
[TBL] [Abstract][Full Text] [Related]
9. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
10. Effect of immunization of bacterial adherence to urothelium.
Uehling DT; Mizutani K; Balish E
Invest Urol; 1978 Sep; 16(2):145-7. PubMed ID: 361628
[TBL] [Abstract][Full Text] [Related]
11. Hexameric immunoglobulin M in humans: desired or unwanted?
Petrušić V; Živković I; Stojanović M; Stojićević I; Marinković E; Dimitrijević L
Med Hypotheses; 2011 Dec; 77(6):959-61. PubMed ID: 21903335
[TBL] [Abstract][Full Text] [Related]
12. Experimental vaccine may curb recurrent urinary tract infections.
Mayo Clin Womens Healthsource; 2004 Jan; 8(1):3. PubMed ID: 14704603
[No Abstract] [Full Text] [Related]
13. [immunization and immune response to pneumococcal vaccination].
Hidalgo H; Inostroza J; Leiva L; Sorensen RU
Rev Med Chil; 1996 Mar; 124(3):287-92. PubMed ID: 9008939
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of conventional and new generation tests for testing the humeral response to Mycoplasma pneumoniae antigens in natural infections in humans. II. Occurrence and level of mycoplasma antibodies in patients with respiratory tract infections].
Rastawicki W
Med Dosw Mikrobiol; 1995; 47(1-2):55-76. PubMed ID: 8523971
[TBL] [Abstract][Full Text] [Related]
15. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.
Kuijpers TW; Weening RS; Out TA
Allergol Immunopathol (Madr); 1992; 20(1):28-34. PubMed ID: 1509985
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
Svennerholm AM
Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of detection of IgM antibodies to Helicobacter pylori.
Alem M; Alem N; Cohen H; England T; Hamedi N; Moussazadeh M; Roth JA; Shen GQ
Exp Mol Pathol; 2002 Feb; 72(1):77-83. PubMed ID: 11784126
[TBL] [Abstract][Full Text] [Related]
18. Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.
Petrušić V; Zivković I; Stojanović M; Stojićević I; Marinković E; Inić-Kanada A; Dimitijević L
Immunol Res; 2011 Oct; 51(1):97-107. PubMed ID: 21786026
[TBL] [Abstract][Full Text] [Related]
19. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.
Carsetti R; Rosado MM; Donnanno S; Guazzi V; Soresina A; Meini A; Plebani A; Aiuti F; Quinti I
J Allergy Clin Immunol; 2005 Feb; 115(2):412-7. PubMed ID: 15696104
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of recurrent urinary infections using Solco Urovac, a polymicrobial vaccine].
Prát V; Matousovic K; Horcicková M; Hatala M; Milotová Z
Cas Lek Cesk; 1989 Aug; 128(35):1106-9. PubMed ID: 2605612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
